Circulating Cell-free DNA-based Epigenetic Biomarker MSEPT9 for Hepatocellular Carcinoma Detection in Cirrhosis

NCT03311152 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

529

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma
Cirrhosis

Interventions

DIAGNOSTIC_TEST: "Epi proColon 2.0 CE" test from Epigenomics, Inc (Berlin, Germany)

Sponsor

Central Hospital, Nancy, France

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]